Article Text

Download PDFPDF
Patient satisfaction survey: substitution of reference etanercept with a biosimilar product
  1. Cristina Martínez-Múgica Barbosa,
  2. Belén Rodríguez de Castro,
  3. Yoar Labeaga Beramendi,
  4. Paloma Terroba Alonso,
  5. Javier Barbazán Vázquez
  1. Pharmacy Department, Hospital de Cabueñes, Gijon, Spain
  1. Correspondence to Cristina Martínez-Múgica Barbosa, Pharmacy Department, Hospital de Cabueñes, Gijon 33394, Spain; cmartinezmugica{at}gmail.com

Abstract

Objectives To assess patient satisfaction after pharmacy-mediated replacement of the originator etanercept prefilled syringe with its biosimilar prefilled pen.

Methods Prospective observational study from March to May 2018, to assess satisfaction with the new drug dispensed. Patients were asked to answer a paper questionnaire with three questions: pain at injection site, ease of administration, and overall patient satisfaction with the change, rated on a scale from 1 (not satisfied) to 5 (extremely satisfied).

Results The questionnaire was given to 134 patients (74 men, 60 women), with an average age of 55 years. 118 patients (88%) were from the Rheumatology Service and 16 patients (12%) from Dermatology. The median treatment duration with etanercept was 61 months. 87 (65%) completed questionnaires were collected. The mean pain score was 3.4. Most patients found administration easy with the biosimilar pen, with an average score of 3.7. Mean overall satisfaction was rated at 3.3, being higher among men, younger patients, and those with shorter duration of treatment.

Conclusions The change of the original product from etanercept to a biosimilar product was acceptable for most of the patients who responded to the survey. Surveys allow us to determine the opinion and preferences of patients, thus achieving higher satisfaction with their treatment. Further research is needed to evaluate the effect of automatic replacement. A collaborative multidisciplinary switching programme should be implemented based on the feedback provided by patients.

  • BIOSIMILAR
  • Etanercept
  • Originator
  • Patient Satisfaction
  • drug substitution (process)
View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.